2020
2020
In the context of the COVID-19 pandemic, Antibiotice supports the Romanian healthcare system by reintroducing two products (Paracetamol and Novocalmin) for COVID-19 treatment and provides hospitals with injectable antibiotics for the associative treatment of complicated infections caused by the virus SARS-CoV-2.
The company is winning the tender organised by the European Commission for one of the most widely used antibiotics in COVID-19 treatment: AmoxiPlus® and is entering the US and UK markets with new COVID-19-associated medicines.
